Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naive men with oligometastatic prostate cancer to bone.

被引：0
|
作者：
Tward, Jonathan David
Johnson, Skyler B.
Kokeny, Kristine E.
Lloyd, Shane
Cannon, Donald Maurice
Dechet, Christopher B.
ONeil, Brock
Stephenson, Robert
Boucher, Kenneth M.
Gupta, Sumati
Swami, Umang
Maughan, Benjamin L.
Agarwal, Neeraj
机构：
[1] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[3] Huntsman Canc Hosp, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
156
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I/II study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.
    Shaya, Justin
    Xie Wanling
    Saraiya, Biren
    Parikh, Mamta
    Folefac, Edmund
    Olson, Adam C.
    Choudhury, Atish Dipankar
    Einstein, David Johnson
    Heath, Elisabeth I.
    Parikh, Rahul Atul
    Kunos, Charles
    Ivy, Percy S.
    LoRusso, Patricia
    Kurzrock, Razelle
    Shapiro, Geoffrey
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [22] Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC)
    Marshall, Catherine Handy
    Park, Jong Chul
    DeWeese, Theodore L.
    King, Serina
    Afful, Michaella
    Hurrelbrink, Julia
    Manogue, Charlotte
    Cotogno, Patrick
    Moldawer, Nancy P.
    Barata, Pedro C.
    Drake, Charles G.
    Posadas, Edwin M.
    Armstrong, Andrew J.
    Sartor, A. Oliver
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Randomized phase-2 study of sipuleucel-T with or without radium-223 in men with asymptomatic/minimally symptomatic bone-metastatic castrate-resistant prostate cancer (CRPC).
    Park, Jong Chul
    Sartor, A. Oliver
    Sullivan, Rana
    King, Serina
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Alpha-emitting Radium-223: two years follow up from a randomized phase II study in patients with bone metastases from hormone refractory prostate cancer
    Nilsson, S.
    Franzen, L.
    Parker, C.
    Bolstad, B.
    Ramdahl, T.
    Thuresson, M.
    Bruland, O.
    EJC SUPPLEMENTS, 2009, 7 (02): : 412 - 412
  • [25] Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study
    Zhou, Tie
    Zhou, Fangjian
    Guo, Jianming
    Shi, Hongcheng
    Yao, Xudong
    Guo, Hongqian
    Yuan, Jian
    Tian, Ye
    Zhang, Xiaodong
    Wang, Shuxia
    Jiang, Yongguang
    Zou, Qing
    Zhou, Daqing
    Li, Hanzhong
    Li, Fang
    Lee, Jae Lyun
    Chen, Chung-Hsin
    Park, Se Hoon
    Ng, Quan Sing
    Ma, Jianhui
    Zheng, Rong
    Ding, Qiang
    Liu, Xingdang
    Li, Rui
    Krissel, Heiko
    Wagner, Volker J.
    Sun, Yinghao
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 462 - 470
  • [26] Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
    Ravit Geva
    Juanita Lopez
    Sarah Danson
    Heikki Joensuu
    Avivit Peer
    Samuel J. Harris
    Fabricio Souza
    Kaline M. C. Pereira
    Ruth Perets
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1092 - 1101
  • [27] Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
    Sun, Y.
    Shi, H.
    Chen, C. -H.
    Lee, J. L.
    Kang, T. W.
    Park, S. H.
    Wu, T. L.
    Ng, Q. S.
    Keam, B.
    Wong, S. C. A.
    Tay, M. H.
    Ding, Q.
    Li, F.
    Ng, D. C. E.
    Liu, X.
    Zhang, Z.
    Guo, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 73 - 74
  • [28] Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
    Geva, Ravit
    Lopez, Juanita
    Danson, Sarah
    Joensuu, Heikki
    Peer, Avivit
    Harris, Samuel J.
    Souza, Fabricio
    Pereira, Kaline M. C.
    Perets, Ruth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1092 - 1101
  • [29] Imaging and pharmacokinetics with escalating doses of Radium-223 chloride in bone-metastatic castration resistant prostate cancer (CRPC) during a phase I study
    Carrasquillo, Jorge
    O'Donoghue, Joseph
    Pandit-Taskar, Neeta
    Aksnes, Anne-Kirsti
    Larson, Steven
    Scher, Howard
    Morris, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [30] Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer
    Ueno, Naoto T.
    Tahara, Rie K.
    Fujii, Takeo
    Reuben, James M.
    Gao, Hui
    Saigal, Babita
    Lucci, Anthony
    Iwase, Toshiaki
    Ibrahim, Nuhad K.
    Damodaran, Senthil
    Shen, Yu
    Liu, Diane D.
    Hortobagyi, Gabriel N.
    Tripathy, Debu
    Lim, Bora
    Chasen, Beth A.
    CANCER MEDICINE, 2020, 9 (03): : 1025 - 1032
12345